Lamotrigine for treatment-refractory bipolar disorder

被引：0
|
作者：
Labbate, LA
Rubey, RN
机构：
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 1997年 / 154卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：1317 / 1317
页数：1
相关论文
共 50 条
  • [1] Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder
    Calabrese, JR
    Bowden, CL
    McElroy, SL
    Cookson, J
    Andersen, J
    Keck, PE
    Rhodes, L
    Bolden-Watson, C
    Zhou, J
    Ascher, JA
    AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (07): : 1019 - 1023
  • [2] Lamotrigine treatment of refractory bipolar disorder
    Fogelson, DL
    Sternbach, H
    JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (06) : 271 - 273
  • [3] Rapid clozapine titration in treatment-refractory bipolar disorder
    Ifteni, Petru
    Correll, Christoph U.
    Nielsen, Jimmi
    Burtea, Victoria
    Kane, John M.
    Manu, Peter
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 166 : 168 - 172
  • [4] Treatment-refractory bipolar disorder: classification to aid in clinical management
    Gajwani, Prashant
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (12) : 1907 - 1915
  • [5] NICE guidance: why not clozapine for treatment-refractory bipolar disorder?
    Bastiampillai, Tarun
    Gupta, Arun
    Allison, Stephen
    Chan, Sherry Kit Wa
    LANCET PSYCHIATRY, 2016, 3 (06): : 502 - 503
  • [6] Is lamotrigine effective for treatment-refractory mania? Reply
    Walden, J
    PHARMACOPSYCHIATRY, 1998, 31 (01) : 35 - 35
  • [7] Lamotrigine for the treatment of bipolar disorder
    Engle, PM
    Heck, AM
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (02) : 258 - 262
  • [8] NICE guidance: why not clozapine for treatment-refractory bipolar disorder? Reply
    Morriss, Richard
    Mayo-Wilson, Evan
    Kendall, Tim
    LANCET PSYCHIATRY, 2016, 3 (06): : 503 - 503
  • [9] Lamotrigine in the treatment of bipolar disorder
    Bhagwagar, Z
    Goodwin, GM
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (08) : 1401 - 1408
  • [10] Lamotrigine in the treatment of resistant bipolar disorder
    Kotler, M
    Matar, MA
    CLINICAL NEUROPHARMACOLOGY, 1998, 21 (01) : 65 - 67
12345